• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给药载体对大鼠体内氟吡禾灵丁酯和乙羧氟草醚经皮吸收的影响。

Effect of dosing vehicle on the dermal absorption of fluazifop-butyl and fomesafen in rats in vivo.

作者信息

Rawlings J M, Hilton J, Trebilcock K L, Woollen B H, Wilks M F

机构信息

Zeneca Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, England.

出版信息

Fundam Appl Toxicol. 1994 Jul;23(1):93-100. doi: 10.1006/faat.1994.1084.

DOI:10.1006/faat.1994.1084
PMID:7958570
Abstract

One important factor which may influence the extent and rate of percutaneous absorption is the dosing vehicle. The purpose of the experiments described was to compare the effect of dosing vehicles of different polarities on the absorption of two herbicides across rat skin in vivo. Rats were dosed dermally with either fluazifop-butyl (logP(oct) 4.5) or fomesafen sodium salt (logP(oct) -1.2) in propylene glycol (PG), octanol (OCT), or ethyl decanoate (ED), and the amount of radioactivity excreted in urine was determined. Absorption rates were estimated from the urinary excretion data and from blood kinetic data derived from intravenously dosed rats. For fluazifop-butyl the average rate of absorption (x10(-2) micrograms/hr-1 +/- SE) was not greatly influenced by the dosing vehicle (OCT, 2.94 +/- 0.08; ED, 3.66 +/- 0.10; PG, 3.95 +/- 0.32) despite relatively large differences in solubility (PG, 38 mg/ml; OCT, and ED, > 600 mg/ml). These results were consistent with the finding that there was at most only a twofold difference in the epidermal membrane:vehicle partition coefficients (km). In contrast, the absorption rate of fomesafen from PG (1.98 +/- 0.04) was approximately half that of ED (3.98 +/- 0.06) and OCT (4.49 +/- 0.08) for the first 30 hr after application and was in keeping with solubility data (PG, 638 mg/ml; OCT, 12 mg/ml; ED, < 10 mg/ml). At later time points the absorption of fomesafen from PG increased; this is discussed in relation to the penetration-enhancing properties of PG.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

可能影响经皮吸收程度和速率的一个重要因素是给药载体。所述实验的目的是比较不同极性的给药载体对两种除草剂在大鼠体内经皮肤吸收的影响。将大鼠经皮给予氟吡甲禾灵丁酯(辛醇/水分配系数logP(oct) 4.5)或乙羧氟草醚钠盐(logP(oct) -1.2),溶剂分别为丙二醇(PG)、辛醇(OCT)或癸酸乙酯(ED),并测定尿中排出的放射性物质的量。根据尿排泄数据以及静脉给药大鼠的血药动力学数据估算吸收速率。对于氟吡甲禾灵丁酯,尽管溶解度存在较大差异(PG为38 mg/ml;OCT和ED均>600 mg/ml),但给药载体对其平均吸收速率(×10(-2)微克/小时-1±标准误)影响不大(OCT为2.94±0.08;ED为3.66±0.10;PG为3.95±0.32)。这些结果与以下发现一致,即表皮膜与载体的分配系数(km)至多仅相差两倍。相比之下,在给药后的前30小时,乙羧氟草醚从PG的吸收速率(1.98±0.04)约为ED(3.98±0.06)和OCT(4.49±0.08)的一半,这与溶解度数据相符(PG为638 mg/ml;OCT为12 mg/ml;ED<10 mg/ml)。在之后的时间点,乙羧氟草醚从PG的吸收增加;这与PG的促渗透特性有关。(摘要截短至250字)

相似文献

1
Effect of dosing vehicle on the dermal absorption of fluazifop-butyl and fomesafen in rats in vivo.给药载体对大鼠体内氟吡禾灵丁酯和乙羧氟草醚经皮吸收的影响。
Fundam Appl Toxicol. 1994 Jul;23(1):93-100. doi: 10.1006/faat.1994.1084.
2
Vehicle effects on in vitro percutaneous absorption through rat and human skin.载体对大鼠和人皮肤体外经皮吸收的影响。
Pharm Res. 1994 Oct;11(10):1396-400. doi: 10.1023/a:1018931503784.
3
Modelling dermal pharmacokinetics using in vitro data. Part I. Fluazifop-butyl in the rat.利用体外数据模拟皮肤药代动力学。第一部分。大鼠体内的氟吡甲禾灵丁酯。
Hum Exp Toxicol. 1993 May;12(3):199-206. doi: 10.1177/096032719301200302.
4
Pharmacokinetics of fluazifop-butyl in human volunteers. II: Dermal dosing.氟吡甲禾灵丁酯在人体志愿者中的药代动力学。II:经皮给药。
Hum Exp Toxicol. 1992 Jul;11(4):247-54. doi: 10.1177/096032719201100402.
5
Modelling dermal pharmacokinetics using in vitro data. Part II. Fluazifop-butyl in man.利用体外数据模拟皮肤药代动力学。第二部分。氟吡甲禾灵丁酯在人体中的情况。
Hum Exp Toxicol. 1993 May;12(3):207-13. doi: 10.1177/096032719301200303.
6
Fate of fluazifop butyl in rat and human skin in vitro.氟吡甲禾灵丁酯在大鼠和人皮肤中的体外代谢情况。
Arch Toxicol. 1993;67(1):44-8. doi: 10.1007/BF02072034.
7
The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skin.
Fundam Appl Toxicol. 1994 Aug;23(2):230-6. doi: 10.1006/faat.1994.1101.
8
Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin.载体和渗透促进剂对甲氨蝶呤和依达曲沙经无毛小鼠皮肤的体外和体内经皮吸收的影响。
Pharm Res. 1997 Aug;14(8):1058-65. doi: 10.1023/a:1012109513643.
9
Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice.静脉注射和经皮给药的三乙醇胺在小鼠体内的吸收、分布、代谢及排泄
Food Chem Toxicol. 2000 Nov;38(11):1043-51. doi: 10.1016/s0278-6915(00)00095-8.
10
Oral pharmacokinetics of fluazifop-butyl in human volunteers.氟吡甲禾灵丁酯在人体志愿者中的口服药代动力学。
Hum Exp Toxicol. 1991 Jan;10(1):39-43. doi: 10.1177/096032719101000107.